0001493152-18-003187.txt : 20180309
0001493152-18-003187.hdr.sgml : 20180309
20180309173018
ACCESSION NUMBER: 0001493152-18-003187
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180226
FILED AS OF DATE: 20180309
DATE AS OF CHANGE: 20180309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richard Gregory
CENTRAL INDEX KEY: 0001717470
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24249
FILM NUMBER: 18681269
MAIL ADDRESS:
STREET 1: C/O INTERPACE DIAGNOSTICS GROUP, INC.
STREET 2: 300 INTERPACE PARKWAY, BUILDING A
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Interpace Diagnostics Group, Inc.
CENTRAL INDEX KEY: 0001054102
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 222919486
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
BUSINESS PHONE: 412-224-6100
MAIL ADDRESS:
STREET 1: MORRIS CORPORATE CENTER 1,
STREET 2: BUILDING C, 300 INTERPACE PARKWAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
FORMER COMPANY:
FORMER CONFORMED NAME: PDI INC
DATE OF NAME CHANGE: 20021113
FORMER COMPANY:
FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC
DATE OF NAME CHANGE: 19980129
4
1
form4.xml
X0306
4
2018-02-26
0
0001054102
Interpace Diagnostics Group, Inc.
IDGX
0001717470
Richard Gregory
C/O INTERPACE DIAGNOSTICS GROUP, INC.
300 INTERPACE PARKWAY
PARSIPPANY
NJ
07054
0
1
0
0
Chief Commerical Officer
Common Stock
2018-02-26
4
M
0
2000
A
3241
D
Common Stock
2018-03-07
4
A
0
28000
A
31241
D
Restricted Stock Units
2018-02-26
4
M
0
2000
0
D
Common Stock
2000
2000
D
Stock Option (right to buy)
1.01
2018-03-07
4
A
0
112000
0
A
2028-03-07
Common Stock
112000
112000
D
Mr. Richard received 6,000 restricted stock units on February 26, 2016. 2,000 restricted stock units vested and 759 restricted stock units were withheld for taxes before Mr. Richard was required to report his holdings, 2,000 restricted stock units vested on February 26, 2018 and the remaining 2,000 restricted stock units will vest on February 26, 2019.
Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the "Issuer").
The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019.
The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer.
/s/ Gregory Richard
2018-03-09